← Back to All Stocks

Coherus Oncology, Inc. (CHRS) Analysis

Generated on: 2025-08-20 19:12:52 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.07
Predicted Price
$0.90
Expected Return
-13.53%
Confidence Score
0.82
RSI (14)
64.39
MACD
0.05
Volume
1,081,964
Float Shares
111,186,498
Reddit Posts
1
News Items
1
SEC Filings
0
Data Points
251

CHRS

Coherus Oncology, Inc.
-13.53%
Price: $1.07
Confidence: 0.82
Reddit
News
Last updated: 2025-08-20 19:12:52

Technical Analysis

RSI: 64.39
MACD: 0.05
Technical Analysis Graph

Risk Analysis

Volatility
95.67%
Max Drawdown
-57.84%
Beta
1.0
Risk Score
81.4

Social Sentiment

76.7
Social Sentiment Score (0-100)

Recent News

News thumbnail
Simply Wall St. - 2025-08-10 14:03
NasdaqGM:CHRS 1 Year Share Price vs Fair Value Explore Coherus Oncology's Fair Values from the Community and select...

Reddit Discussions

r/pennystocks - 2025-07-26 01:03 - Score: 45 - Comments: 48
 **Bonus for y’all**: Here’s a gift for anyone who wants to grab it. I’ve done the homework on this one and I see serious potential. If CHRS catches fire, we could be looking at a run to **$5–$7** short term. Take it or leave it . I’m in. **$CHRS Earnings Preview – High Risk, High Reward Setup Incoming**   **What to Know Before the Call:**  **Transformation Complete** CHRS is now *Coherus Oncology*. fully focused on immuno-oncology after selling its biosimilar unit *UDENYCA* for up to **$55...

Recent SEC Filings

No recent SEC filings found.